New Key Statistics Module, Z-Score and F-Score
XCNQ:INNO Key Ratios
Market Cap C$ M | 78.58 |
Enterprise Value C$ M | 73.32 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 13.33 |
Price/Sales | 3.94 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 18.00 |
EPS (TTM) C$ | -0.02 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -4.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -13.44 |
EV-to-EBITDA | -13.55 |
PEG | -- |
Shares Outstanding M | 280.66 |
Net Margin (%) | -34.60 |
Operating Margin % | -27.99 |
Pre-tax Margin (%) | -29.72 |
Quick Ratio | 1.99 |
Current Ratio | 2.68 |
ROA % (ttm) | -71.15 |
ROE % (ttm) | -93.09 |
ROIC % (ttm) | -201.56 |
Dividend Yield % | -- |
Altman Z-Score | 7.87 |
XCNQ:INNO Number of Guru Trades
XCNQ:INNO Volume of Guru Trades
Gurus Latest Trades with XCNQ:INNO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:INNO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
InnoCan Pharma Corp Insider Transactions
No Available Data